Benchtop NMR urine metabolomics for diagnosing pulmonary tuberculosis


Por: Comella-del-Barrio, P, Rodríguez, I, Bimba, JS, Osazuwa, O, Alaran, R, Alonso-Moreno, P, Blasco-Iturri, Z, Miguel-Coello, AB, Cuevas, LE, Ruiz-Cabello, J, Izquierdo-Garcia, JL and Domínguez, J

Publicada: 19 nov 2025 Ahead of Print: 19 nov 2025
Resumen:
Tuberculosis (TB) remains a major global health issue, especially in resource-limited settings, where rapid and accurate diagnosis is critical yet often lacking. Nuclear magnetic resonance (NMR)-based metabolomics has emerged as a promising tool for identifying disease-specific biomarkers. This study assessed the diagnostic potential of urinary metabolomics using high-resolution (HR-)NMR and benchtop NMR (bNMR) in Nigerian adults with presumed pulmonary TB, including individuals with and without HIV. Urine samples were analysed by HR-NMR and bNMR. Multivariate analysis was used to develop classification models based on confirmed TB status. Key discriminant metabolites were identified. In HIV-negative individuals, HR-NMR achieved 84% sensitivity and 86% specificity, while bNMR reached 83% and 84%, respectively. In people living with HIV, HR-NMR reached 75% sensitivity and 70% specificity; bNMR achieved 90% and 46%. Both models met or exceeded WHO sensitivity criteria for non-sputum-based TB diagnostics. Thirteen discriminatory metabolites were identified, with eight consistent with previous studies. These findings suggest common metabolic signatures of TB, regardless of HIV status. Urinary NMR-based metabolomics shows strong potential for TB diagnosis in high TB/HIV burden settings. HR-NMR provides excellent accuracy, while bNMR offers a cost-effective alternative. Further studies are needed to validate and optimise this approach for clinical use.

Filiaciones:
Comella-del-Barrio, P:
 Inst Invest Germans Trias & Pujol, Barcelona 08916, Spain

 Gregorio Maranon Mother & Child Hosp, Paediat Infect Dis Unit, Madrid 28009, Spain

 Inst Salud Carlos III, CIBER Enfermedades Infecciosas CIBERINFEC, Madrid 28029, Spain

Rodríguez, I:
 Univ Complutense Madrid, Pharm Sch, Dept Chem Pharmaceut Sci, Madrid 28040, Spain

 Univ Complutense Madrid, Inst Pluridisciplinar, NMR & Imaging Biomed Grp, Madrid 28040, Spain

 Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain

Bimba, JS:
 Bingham Univ, Zankli Res Ctr, Karu 961105, Nigeria

 Bingham Univ, Dept Community Med, Karu 961105, Nigeria

Osazuwa, O:
 Bingham Univ, Zankli Res Ctr, Karu 961105, Nigeria

 Bingham Univ, Dept Community Med, Karu 961105, Nigeria

Alaran, R:
 Univ Liverpool Liverpool Sch Trop Med, Ctr Drugs & Diagnost, Dept Clin Sci, Liverpool L3 5QA, England

Alonso-Moreno, P:
 Univ Complutense Madrid, Pharm Sch, Dept Chem Pharmaceut Sci, Madrid 28040, Spain

 Univ Complutense Madrid, Inst Pluridisciplinar, NMR & Imaging Biomed Grp, Madrid 28040, Spain

Blasco-Iturri, Z:
 Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain

 Basque Res & Technol Alliance BRTA, CIC biomaGUNE, Donostia San Sebastian 20014, Spain

 Justus Liebig Univ, Univ Giessen & Marburg Lung Ctr UGMLC, Inst Lung Hlth ILH, German Ctr Lung Res DZL, Giessen, Germany

 Justus Liebig Univ, Cardiopulm Inst CPI, Giessen, Germany

Miguel-Coello, AB:
 Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain

 Basque Res & Technol Alliance BRTA, CIC biomaGUNE, Donostia San Sebastian 20014, Spain

Cuevas, LE:
 Univ Liverpool Liverpool Sch Trop Med, Ctr Drugs & Diagnost, Dept Clin Sci, Liverpool L3 5QA, England

Ruiz-Cabello, J:
 Univ Complutense Madrid, Pharm Sch, Dept Chem Pharmaceut Sci, Madrid 28040, Spain

 Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain

 Basque Res & Technol Alliance BRTA, CIC biomaGUNE, Donostia San Sebastian 20014, Spain

 Basque Fdn Sci, IKERBASQUE, Bilbao 48009, Spain

Izquierdo-Garcia, JL:
 Univ Complutense Madrid, Pharm Sch, Dept Chem Pharmaceut Sci, Madrid 28040, Spain

 Univ Complutense Madrid, Inst Pluridisciplinar, NMR & Imaging Biomed Grp, Madrid 28040, Spain

 Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain

:
 Inst Invest Germans Trias & Pujol, Barcelona 08916, Spain

 Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid 28029, Spain

 Univ Autonoma Barcelona, Biosci Fac, Dept Genet & Microbiol, Barcelona, Spain
ISSN: 20452322





Scientific Reports
Editorial
Nature Publishing Group, HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY, Reino Unido
Tipo de documento: Article
Volumen: 15 Número: 1
Páginas: 40881-40881
WOS Id: 001619356000003
ID de PubMed: 41258035
imagen Green Submitted, gold

MÉTRICAS